104.2K
Downloads
228
Episodes
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
Episodes
2 days ago
2 days ago
In this special episode of Molecule to Market, recorded at this year’s CDMO Live in Rotterdam, industry leaders come together to assess the evolving state of the contract development and manufacturing sector. Raman is the panel moderator, joined by:
They unpack cautious optimism in the face of lingering market uncertainties and geopolitical tension, you’ll hear:
- How CDMOs are adapting to early-stage funding strain and evolving pricing models
- The impact of rising interest rates, tariffs, and global trade policy on pharma outsourcing
- Capacity and talent constraints facing CDMOs in new therapeutic modalities
- Why integrated models and scenario planning are key to future-proofing operations
This episode offers timely insight into the challenges and opportunities shaping the next phase of growth for CDMOs worldwide.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.
No comments yet. Be the first to say something!